1. Home
  2. Live Updates
  3. Matthew pianko

Live Breaking News & Updates on Matthew pianko

Stay informed with the latest breaking news from Matthew pianko on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Matthew pianko and stay connected to the pulse of your community

Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma

Panelists provide concluding perspectives on the operationalization of bispecific antibodies for multiple myeloma.

Matthew-pianko , Ryan-haumschild , Anthony-perissinotti , Practice-pearls , Pharmacy-times ,

Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma

Experts discuss their institution’s implementation of step-up dosing for bispecific antibodies and share their best practices.

Matthew-pianko , Anthony-perissinotti , Ryan-haumschild , Interesting-american-society-of-hematologyabstracts , Practice-pearls , American-society , Pharmacy-times , Step-up-dosing , Bispecific-antibodies , Myeloma , Outpatient , Infrastructure

The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies

Matthew Pianko, MD, outlines the logistical considerations involved when implementing bispecific antibodies for the treatment of multiple myeloma, including the roles of the project champion and other stakeholders as part of a multidisciplinary team.

Michigan , United-states , Matthew-pianko , Anthony-perissinotti , Ryan-haumschild , University-of-michigan-health , Practice-pearls , Michigan-health , Pharmacy-times , Physician-champion , Project-champion , Bispecific-antibodies

Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody

Expert panelists provide an overview of adverse events associated with bispecific antibodies for the treatment of multiple myeloma along with best practices for monitoring and treating adverse events.

Anthony-perissinotti , Ryan-haumschild , Matthew-pianko , Practice-pearls , Immune-effector-cell , Associated-encephalopathyscoring , Pharmacy-times , Multiple-myeloma , Bispecific , Bispecific-antibodies , Adverse-event-profile

Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies

Anthony Perissinotti, PharmD, BCOP, provides an overview of the REMS program requirements for bispecific antibodies and describes the processes, procedures, and training programs implemented at his institution.

Ryan-haumschild , Matthew-pianko , Anthony-perissinotti , Drug-administration , Practice-pearls , Multiple-myeloma- , Bispecific- , Bispecific-antibodies , Adverse-events , Rems , Risk-evaluation-and-mitigation-strategy , Crs

Key Considerations in Treatment Selection for Patients With Multiple Myeloma

Experts describe considerations for selecting appropriate patients for treatment with a bispecific antibody, including prior therapies for relapsed or refractory multiple myeloma. Strategies to quickly prepare patients for treatment with a bispecific antibody are also discussed.

Anthony-perissinotti , Ryan-haumschild , Matthew-pianko , Practice-pearls , Prior-lines-of-therapy , Relapsed-refractory-multiple-myeloma , Bispecific-antibodies , Adverse-event-profile , Icans , Immune-effector-cell-associated-neurotoxicity-syndrome , Cytotoxic-chemotherapy

Impact of Bispecific Antibodies on Multiple Myeloma Treatment

Experts discuss the impact of advances in the treatment of multiple myeloma on patient care.

Anthony-perissinotti , Matthew-pianko , Ryan-haumschild , Bispecific-antibodies , Multiple-myeloma , Health-care-system , Relapse-refractory-multiple-myeloma , Teclistamab , Elranatamab , Talquetamab , Bcma

Local Navy veteran, cancer survivor inspires others not to give up the fight

Bone pain and fractures are the most common symptoms, along with fatigue, bruising, frequent infections, and kidney damage.

United-states , American , Jeffrey-zonder , Hal-anderson , Matthew-pianko , Myeloma-research-foundation , Wayne-state-university-school-of-medicine , Professor-of-oncology-at-karmanos-cancer-institute , Team-for-cures , Willow-metro-park , New-boston , Yale-medicine

DBusiness Daily Update: MEDC Initiative Sends $10M to Nearly 700 Small Businesses, Oregon Company Creates 300+ Metro Detroit Jobs, and More


DBusiness Magazine
DBusiness Daily Update: MEDC Initiative Sends $10M to Nearly 700 Small Businesses, Oregon Company Creates 300+ Metro Detroit Jobs, and More
Our roundup of the latest news from metro Detroit and Michigan businesses as well as announcements from government agencies, including updates about the COVID-19 pandemic. To share a business or nonprofit story, please send us a message.
Courtesy of Bridge, as of March 4
Our roundup of the latest news from metro Detroit and Michigan businesses as well as announcements from government agencies, including updates about the COVID-19 pandemic. To share a business or nonprofit story, please send us a message.

Southfield , Michigan , United-states , Oakland-county , Detroit , Farmington-hills , Oregon , Bloomfield-hills , American , Dave-coulter , Lauren-rakolta , Andrew-coulouris